A. Fernández-Olmos

MALDI-TOF MS improves routine identification of non-fermenting Gram negative isolates from cystic fibrosis patients

A. Fernández-Olmos, María García-Castillo, María‐Isabel Morosini et al. · Journal of Cystic Fibrosis · 2011 · 102 citations · Full text

Medical Microbiology, Dysbiosis, Pathogen Detection +10

Non-diphtheriae Corynebacterium species: an emerging respiratory pathogen

María Diez‐Aguilar, Patricia Ruíz-Garbajosa, A. Fernández-Olmos et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2012 · 85 citations

Pathogenic Microbiology, Klebsiella Pneumoniae, Microbiology +4

MALDI-TOF mass spectrometry as a tool for the discrimination of high-risk Escherichia coli clones from phylogenetic groups B2 (ST131) and D (ST69, ST405, ST393)

Ângela Novais, Clara Sousa, Juan de Dios Caballero et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2014 · 50 citations

Phylogenetic Groups B2, Microbial Systematics, Microbial Genetics +6

In vitro prevention of Pseudomonas aeruginosa early biofilm formation with antibiotics used in cystic fibrosis patients

A. Fernández-Olmos, María García-Castillo, Luís Máiz et al. · International Journal of Antimicrobial Agents · 2012 · 44 citations

Pathogenic Microbiology, Antimicrobial Susceptibility, Antibiotics +10

Population Structure and Antimicrobial Susceptibility of Both Nonpersistent and Persistent Pseudomonas aeruginosa Isolates Recovered from Cystic Fibrosis Patients

A. Fernández-Olmos, María García-Castillo, José María Alba et al. · Journal of Clinical Microbiology · 2013 · 37 citations · Full text

Antimicrobial Resistance Gene, Pathogenic Microbiology, Antimicrobial Susceptibility +13